<div id="main-content">
<h2 class="title"><span class="in"><span style="color: rgb(255, 255, 255);">Immune Pathways</span></span></h2>
<div class="article">
<div class="article-content">
<div class="RichTextElement">
<div><p><br/><span style="font-size: 16px; font-family: Arial;">The adaptive immune system is comprised of two interrelated immune pathways âÂ humoral and cell-mediated immunity</span></p><ul><li><span style="font-size: 16px; font-family: Arial;">Both pathways involve elements of the innate immune system to coordinate their respective immune reactions</span></li></ul><p><span style="font-size: 16px; font-family: Arial;"><br/></span></p><p><span style="font-size: 18px; font-family: Arial;"><strong>Humoral Immunity</strong></span></p><p><span style="font-size: 16px; font-family: Arial;">Humoral immunity describes the pathway by which antibodies are produced by B lymphocytes to target <em>exogenous</em> antigens</span></p><ul><li><span style="font-family: Arial; font-size: 16px;">When macrophages engulf exogenous pathogens, they digest them within lysosomes to release antigenic fragments</span></li><li><span style="font-family: Arial; font-size: 16px;">These fragments are presented on special surface receptors (MHC class II) that denote the material as being foreign</span></li><li><span style="font-family: Arial; font-size: 16px;">The antigens are presented to helper T cells, which in turn secrete cytokines to activate the appropriate B lymphocytes</span></li><li><span style="font-family: Arial; font-size: 16px;">The specific B lymphocytes divide and differentiate (clonal selection) to form antibody producing plasma cells</span></li></ul><p><span style="font-size: 16px; font-family: Arial;"><br/></span></p><p><span style="font-size: 18px; font-family: Arial;"><strong>Cell-mediated Immunity</strong></span></p><p><span style="font-size: 16px; font-family: Arial;">Cell-mediated immunity describes a pathway that does not result in antigen production but instead targets <em>endogenous</em> antigens</span></p><ul><li><span style="font-size: 16px; font-family: Arial;">Cancerous and virus-infected cells involve the bodyâs own cells and thus are not recognised as foreign, evading normal detection</span></li><li><span style="font-size: 16px; font-family: Arial;">These cells may instead present antigenic fragments as a complex with their own self markers (MHC class I)</span></li><li><span style="font-size: 16px; font-family: Arial;">When helper T cells identify these cells, they stimulate a second type of T lymphocyte â cytotoxic T cells (T<sub>C</sub> cells)</span></li><li><span style="font-size: 16px; font-family: Arial;">Cytotoxic T cells show specificity to particular antigens and will bind to the presented antigen and release perforating enzymes</span></li><li><span style="font-size: 16px; font-family: Arial;">These enzymes cause the infected / cancerous cell to by lysed, preventing the further spread of infection</span></li><li><span style="font-size: 16px; font-family: Arial;">Virus infected cells can also be destroyed non-specifically by NK cells, which respond to interferon released by the infected cell</span></li></ul><p><span style="font-size: 16px; font-family: Arial;"><br/></span></p><p style="text-align: center;"><u><span style="font-size: 18px; font-family: Arial;"><strong>Summary of Adaptive Immune Pathways</strong></span></u></p>
<div class="first graphic-container wide center ImageElement">
<div class="graphic">
<div class="figure-content">
<!-- sandvox.ImageElement --><img alt="immune pathways" height="461" src="../../../_Media/immune-pathways_med.jpeg" width="643"/>
<!-- /sandvox.ImageElement --></div>
</div>
</div><p><span style="font-size: 16px; font-family: Arial;"><br/></span></p>
</div>
</div>
</div> <!-- /article-content -->
<div class="article-info">
</div> <!-- /article-info -->
</div> <!-- /article -->
</div>